Sol-Gel Technologies (SLGL) entered into a product purchase agreement with a subsidiary of Mayne Pharma Group (MAYNF) for the sale and exclusive license of the U.S. rights to EPSOLAY and TWYNEO.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Urogen Pharma (URGN – Research Report) and Ligand Pharma (LGND – Research Report) with bullish ...

Along with Almirall and Biogen, the company has also teamed up with Zuellig Pharma on prescription digital therapeutics in Asia and with health insurance company Anthem (shortly to be known as ...

05:51 – What Ben thinks pharma is doing wrong with regards to publication bias and the lack of transparency. 13:54 – What organisations Ben thinks are making a positive change in this area.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

After the gunfire, they saw it was a cell phone. Lawyers representing Tinsley’s family said Tuesday that they are troubled by what they described as a lack of transparency surrounding Steele’s ...